News

CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced the publication of preclinical data demonstrating the induction of robust antibody and T cell responses of its COVID-19 vaccine...

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the registration of the Russian Sputnik V vaccine against coronavirus by the National Agency of Pharmaceutical Products of People's Democratic Republic of Algeria. The vaccine was registered under the...

AvantGen, Inc., a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager generation, announced licensing of a panel of its anti-SARS-CoV-2 antibody clones to IGM Biosciences...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Kuehne+Nagel, a world-leading logistics company, announced that they have agreed an international supply chain arrangement to provide distribution and storage of the Covid-19 Vaccine Moderna. This...

Dr Reddy’s Laboratories (DRL) on Monday announced the start of its phase 3 clinical trial of Russia's Sputnik V Covid-19 vaccine after receiving clearance from the independent Data and Safety Monitoring Board (DSMB). DSMB’s clearance is based on the safety...

Bharat Biotech inked a purchase agreement with the Government of India on January 11 to provide 55 lakh doses of COVID-19 vaccine Covaxin at Rs 295 per dose. The Indian pharma firm will be providing its coronavirus vaccine directly to...

The government has placed orders in advanced commitments for over 6 crore doses of Covid-19 vaccine from Serum Institute of India (SII) and Bharat Biotech for inoculating 3 crore healthcare and frontline workers in the first phase of the...